Details of Drug-Metabolizing Enzyme (DME)

General Information of Drug-Metabolizing Enzyme (DME) (ID: DEUP4DA)

DME Name Thioredoxin reductase TR1 (TXNRD1)
Synonyms
Cytoplasmic thioredoxin reductase 1; KM-102-derived reductase-like factor; Gene associated with retinoic and IFN-induced mortality 12 protein; Gene associated with retinoic and interferon-induced mortality 12 protein; GRIM-12; GRIM12; KDRF; TR; TXNRD1
Gene Name TXNRD1
UniProt ID
TRXR1_HUMAN
INTEDE ID
DME0210
Gene ID
7296
EC Number EC: 1.8.1.9
Oxidoreductase
Sulfur donor oxidoreductase
NAD/NADP acceptor oxidoreductase
EC: 1.8.1.9
Lineage Species: Homo sapiens
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Sequence
MGCAEGKAVAAAAPTELQTKGKNGDGRRRSAKDHHPGKTLPENPAGFTSTATADSRALLQ
AYIDGHSVVIFSRSTCTRCTEVKKLFKSLCVPYFVLELDQTEDGRALEGTLSELAAETDL
PVVFVKQRKIGGHGPTLKAYQEGRLQKLLKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKE
AAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKV
EETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEK
IYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLA
GIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVV
AQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIY
AIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKA
VEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQ
GFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCUG
Function This enzyme possesses glutaredoxin activity as well as thioredoxin reductase activity and induces actin and tubulin polymerization, leading to formation of cell membrane protrusions.
KEGG Pathway
Hepatocellular carcinoma (hsa05225 )
Pathways in cancer (hsa05200 )
Selenocompound metabolism (hsa00450 )
Reactome Pathway
Interconversion of nucleotide di- and triphosphates (R-HSA-499943 )
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se (R-HSA-2408550 )
Metabolism of ingested MeSeO2H into MeSeH (R-HSA-5263617 )
PPARA activates gene expression (R-HSA-1989781 )
TP53 Regulates Metabolic Genes (R-HSA-5628897 )
Uptake and function of diphtheria toxin (R-HSA-5336415 )
Detoxification of Reactive Oxygen Species (R-HSA-3299685 )

Molecular Interaction Atlas (MIA) of This DME

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DME
1 Approved Drug(s) Metabolized by This DME
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [6]
1 Investigative Drug(s) Metabolized by This DME
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenious acid DMB7GPA N. A. N. A. Investigative [6]

Molecular Expression Atlas (MEA) of This DME

Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This DME
Disease Name ICD 11 Studied Tissue p-value Fold-Change Z-score
Acute myelocytic leukaemia 2B33.1 Bone marrow 6.07E-05 1.21E-01 5.58E-01
Alopecia ED70 Skin from scalp 3.07E-08 -4.23E-01 -1.38E+00
Alzheimer's disease 8A20 Entorhinal cortex 4.61E-01 7.08E-03 5.11E-02
Ankylosing spondylitis FA92.0 Pheripheral blood 3.07E-01 8.82E-02 3.79E-01
Aortic stenosis BB70 Calcified aortic valve 3.21E-01 -1.70E-01 -2.93E-01
Apnea 7A40 Hyperplastic tonsil 1.94E-02 6.97E-01 2.39E+00
Arthropathy FA00-FA5Z Peripheral blood 2.49E-02 1.62E-01 1.42E+00
Asthma CA23 Nasal and bronchial airway 8.26E-07 2.17E-01 5.38E-01
Atopic dermatitis EA80 Skin 2.28E-02 -7.77E-02 -1.87E+00
Autism 6A02 Whole blood 9.56E-02 2.59E-02 1.31E-01
Autoimmune uveitis 9A96 Peripheral monocyte 1.18E-01 7.32E-02 4.35E-01
Autosomal dominant monocytopenia 4B04 Whole blood 2.37E-01 4.31E-01 1.44E+00
Bacterial infection of gingival 1C1H Gingival tissue 2.25E-15 2.86E-01 1.47E+00
Batten disease 5C56.1 Whole blood 9.92E-01 4.83E-03 4.81E-02
Behcet's disease 4A62 Peripheral blood 8.15E-01 -1.80E-02 -9.44E-02
Bipolar disorder 6A60-6A6Z Prefrontal cortex 8.66E-01 5.01E-03 5.80E-02
Bladder cancer 2C94 Bladder tissue 8.21E-02 -1.38E-01 -3.05E-01
Breast cancer 2C60-2C6Z Breast tissue 6.55E-06 7.49E-02 2.23E-01
Cardioembolic stroke 8B11.20 Whole blood 8.83E-03 8.23E-02 5.81E-01
Cervical cancer 2C77 Cervical tissue 3.89E-06 2.69E-01 1.47E+00
Childhood onset rheumatic disease FA20.Z Peripheral blood 7.59E-01 2.02E-04 6.09E-04
Chronic hepatitis C 1E51.1 Whole blood 4.04E-01 1.30E-01 5.95E-01
Chronic obstructive pulmonary disease CA22 Lung tissue 7.31E-01 -1.62E-02 -7.85E-02
Chronic obstructive pulmonary disease CA22 Small airway epithelium 2.24E-04 1.42E-01 4.36E-01
Chronic rhinosinusitis CA0A Sinus mucosa tissue 1.61E-01 -1.57E-01 -8.46E-01
Colon cancer 2B90 Colon tissue 9.26E-01 9.84E-03 5.28E-02
Coronary artery disease BA80-BA8Z Peripheral blood 9.19E-01 -2.06E-02 -6.21E-02
Diffuse large B-cell lymphoma 2A81 Tonsil tissue 8.04E-01 1.01E-01 2.86E-01
Endometriosis GA10 Endometrium tissue 1.99E-01 2.44E-01 3.46E-01
Familial hypercholesterolemia 5C80.00 Peripheral blood 6.39E-01 -3.05E-02 -2.12E-01
Familial hypercholesterolemia 5C80.00 Whole blood 4.02E-04 2.15E-01 1.34E+00
Gastric cancer 2B72 Gastric tissue 1.01E-01 2.91E-01 1.22E+00
Glioblastopma 2A00.00 Nervous tissue 4.04E-45 1.91E-01 8.05E-01
Glioma 2A00.0Y-2A00.0Z Brain stem tissue 6.30E-01 -1.41E-01 -1.08E+00
Glioma 2A00.0Y-2A00.0Z White matter tissue 2.41E-01 1.90E-02 4.49E-02
Head and neck cancer 2D42 Head and neck tissue 4.49E-01 2.20E-01 2.91E-01
HIV-associated neurocognitive impairment 8A2Y-8A2Z White matter tissue 6.79E-01 -8.46E-03 -5.01E-02
Huntington's disease 8A01.10 Whole blood 8.66E-01 3.49E-02 1.36E-01
Idiopathic pulmonary fibrosis CB03.4 Lung tissue 9.65E-03 -6.19E-01 -1.80E+00
Immunodeficiency 4A00-4A20 Peripheral blood 9.96E-05 1.72E-01 2.89E+00
Influenza 1E30 Whole blood 8.47E-02 -6.84E-01 -1.70E+00
Interstitial cystitis GC00.3 Bladder tissue 2.25E-01 2.15E-01 7.94E-01
Intracranial aneurysm 8B01.0 Intracranial artery 6.29E-01 -2.54E-02 -1.17E-01
Irritable bowel syndrome DD91.0 Rectal colon tissue 8.76E-02 7.47E-02 2.23E-01
Ischemic stroke 8B11 Peripheral blood 6.85E-03 -1.23E-01 -1.48E+00
Juvenile idiopathic arthritis FA24 Peripheral blood 5.11E-01 6.82E-02 1.34E-01
Lateral sclerosis 8B60.4 Skin 6.03E-01 -6.92E-02 -2.59E-01
Lateral sclerosis 8B60.4 Cervical spinal cord 6.64E-01 6.01E-02 1.45E-01
Liver cancer 2C12.0 Liver tissue 1.75E-19 5.20E-01 1.77E+00
Liver failure DB99.7-DB99.8 Liver tissue 9.19E-01 8.14E-02 3.32E-01
Lung cancer 2C25 Lung tissue 5.07E-23 1.88E-01 8.14E-01
Lupus erythematosus 4A40 Whole blood 8.08E-03 1.49E-01 4.62E-01
Major depressive disorder 6A70-6A7Z Hippocampus 8.24E-02 4.84E-02 5.90E-01
Major depressive disorder 6A70-6A7Z Whole blood 8.53E-03 7.86E-02 4.66E-01
Melanoma 2C30 Skin 5.49E-01 2.15E-01 3.67E-01
Multiple myeloma 2A83.1 Peripheral blood 2.20E-01 -1.38E-01 -4.40E-01
Multiple myeloma 2A83.1 Bone marrow 4.64E-06 3.60E-01 3.81E+00
Multiple sclerosis 8A40 Plasmacytoid dendritic cells 1.59E-01 -2.58E-01 -1.04E+00
Myelodysplastic syndrome 2A36-2A3Z Bone marrow 2.33E-01 -3.63E-02 -2.40E-01
Myelofibrosis 2A20.2 Whole blood 2.06E-01 -5.50E-02 -4.17E-01
Myocardial infarction BA41-BA50 Peripheral blood 4.49E-01 -4.44E-02 -1.25E-01
Myopathy 8C70.6 Muscle tissue 3.75E-01 1.92E-01 7.14E-01
Neonatal sepsis KA60 Whole blood 2.93E-17 2.89E-01 1.50E+00
Neuroectodermal tumour 2A00.11 Brain stem tissue 6.07E-07 7.64E-01 3.49E+00
Non-alcoholic fatty liver disease DB92 Liver tissue 4.77E-01 1.12E-01 3.94E-01
Obesity related type 2 diabetes 5A11 Omental adipose tissue 4.26E-01 -3.37E-01 -6.76E-01
Olive pollen allergy CA08.00 Peripheral blood 4.21E-01 -1.39E-01 -7.43E-01
Oral cancer 2B6E Oral tissue 7.00E-12 6.36E-01 1.74E+00
Osteoarthritis FA00-FA0Z Synovial tissue 1.42E-01 2.01E-01 4.79E-01
Osteoporosis FB83.1 Bone marrow 7.55E-01 3.22E-02 1.49E-01
Ovarian cancer 2C73 Ovarian tissue 2.92E-01 2.47E-01 6.10E-01
Pancreatic cancer 2C10 Pancreas 1.05E-03 2.74E-01 1.13E+00
Parkinson's disease 8A00.0 Substantia nigra tissue 3.04E-01 2.02E-02 7.71E-02
Pediatric respiratory syncytial virus infection CA40.11 Peripheral blood 9.11E-04 1.20E-01 1.09E+00
Pituitary cancer 2D12 Pituitary tissue 6.56E-01 1.49E-02 7.90E-02
Pituitary gonadotrope tumour 2D12 Pituitary tissue 4.52E-01 -3.05E-02 -2.26E-01
Polycystic ovary syndrome 5A80.1 Vastus lateralis muscle 1.87E-01 -8.54E-02 -6.00E-01
Polycythemia vera 2A20.4 Whole blood 4.06E-02 6.80E-02 4.97E-01
Pompe disease 5C51.3 Biceps muscle 7.90E-01 -1.73E-02 -1.42E-01
Preterm birth KA21.4Z Myometrium 3.19E-03 6.11E-01 2.68E+00
Prostate cancer 2C82 Prostate 2.13E-01 3.26E-01 6.20E-01
Psoriasis EA90 Skin 1.87E-30 4.09E-01 2.10E+00
Rectal cancer 2B92 Rectal colon tissue 9.56E-01 1.18E-02 1.17E-01
Renal cancer 2C90-2C91 Kidney 4.81E-03 3.64E-01 1.05E+00
Retinoblastoma 2D02.2 Uvea 1.81E-09 4.56E-01 4.68E+00
Rheumatoid arthritis FA20 Synovial tissue 2.35E-03 3.51E-02 1.89E-01
Rhinovirus infection CA42.1 Nasal epithelium tissue 1.37E-01 -6.07E-02 -4.24E-01
Schizophrenia 6A20 Prefrontal cortex 1.93E-01 -2.91E-02 -1.57E-01
Schizophrenia 6A20 Superior temporal cortex 9.21E-01 -1.11E-02 -7.59E-02
Scleroderma 4A42.Z Whole blood 5.52E-03 5.31E-02 5.87E-01
Seizure 8A60-8A6Z Whole blood 3.15E-02 -2.17E-01 -1.08E+00
Sensitive skin EK0Z Skin 9.21E-01 2.29E-02 2.96E-01
Sepsis with septic shock 1G41 Whole blood 1.57E-38 2.77E-01 1.41E+00
Shwachman-Diamond syndrome 3A70.0 Bone marrow 1.12E-01 -1.73E-01 -1.09E+00
Sickle cell disease 3A51.0-3A51.3 Peripheral blood 9.48E-01 -5.03E-02 -1.47E-01
Simpson golabi behmel syndrome LD2C Adipose tissue 5.59E-01 -5.39E-02 -3.23E-01
Sjogren's syndrome 4A43.2 Salivary gland tissue 2.11E-01 2.89E-01 1.20E+00
Skin cancer 2C30-2C3Z Skin 1.24E-50 5.49E-01 2.26E+00
Thrombocythemia 3B63 Whole blood 4.04E-01 -7.01E-02 -5.29E-01
Thrombocytopenia 3B64 Whole blood 3.74E-01 -4.80E-01 -7.18E-01
Thyroid cancer 2D10 Thyroid 1.20E-05 -1.59E-01 -8.41E-01
Tibial muscular dystrophy 8C75 Muscle tissue 9.40E-05 -2.71E-01 -1.69E+00
Tuberous sclerosis complex LD2D.2 Perituberal tissue 4.34E-01 -9.80E-02 -9.97E-01
Type 2 diabetes 5A11 Liver tissue 7.78E-01 -1.11E-02 -1.69E-01
Ureter cancer 2C92 Urothelium 6.44E-01 -4.53E-02 -6.33E-02
Uterine cancer 2C78 Endometrium tissue 1.08E-19 3.60E-01 1.03E+00
Vitiligo ED63.0 Skin 5.97E-01 -6.18E-03 -6.76E-02
------------------------------------------------------------------------------------
⏷ Show the Full List of DME Expression Under 107 Diseases

The Drug Therapeutic Target (DTT) Role of This DME

DME DTT Name Cytoplasmic thioredoxin reductase (TXNRD1) DTT Info
DME DTT Type Successful
1 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fotemustine DMV62ED Solid tumour/cancer 2A00-2F9Z Approved [1]
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Spermidine DMVJNFI Plaque psoriasis EA90.0 Phase 3 [1]
57 Patented Agent(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
4-aryl quinol derivative 1 DMEMYDZ N. A. N. A. Patented [2]
4-aryl quinol derivative 2 DM7TW5Z N. A. N. A. Patented [2]
4-aryl quinol derivative 3 DM05V8Q N. A. N. A. Patented [2]
4-aryl quinol derivative 4 DM5IWX2 N. A. N. A. Patented [2]
4-aryl quinol derivative 5 DMWB2YX N. A. N. A. Patented [2]
4-aryl quinol derivative 7 DMC3KTB N. A. N. A. Patented [2]
Acyl oxymethyl acrylamide ester derivative 1 DMXTUE1 N. A. N. A. Patented [2]
Acyl oxymethyl acrylamide ester derivative 2 DMU8OIL N. A. N. A. Patented [2]
Benzisoselenazolone difluorocytidine derivative 1 DMF01AR N. A. N. A. Patented [2]
Binuclear gold(I) compound 1 DM5WN0U N. A. N. A. Patented [2]
Binuclear gold(I) compound 2 DM5WAGC N. A. N. A. Patented [2]
Binuclear gold(I) compound 3 DM94TKW N. A. N. A. Patented [2]
Bis-sulfonamide derivative 1 DMLV9UR N. A. N. A. Patented [2]
Bis-sulfonamide derivative 2 DMR0ANI N. A. N. A. Patented [2]
Disulfide compound 1 DMTYL68 N. A. N. A. Patented [2]
Disulfide compound 2 DM6ON31 N. A. N. A. Patented [2]
Golden phosphorous acetyletic compound 1 DMVAKUI N. A. N. A. Patented [2]
Golden phosphorous acetyletic compound 2 DMYJ15A N. A. N. A. Patented [2]
Golden phosphorous acetyletic compound 3 DMRUCK8 N. A. N. A. Patented [2]
Metal complex derivative 1 DMUOW3T N. A. N. A. Patented [2]
Metal complex derivative 2 DM0BTH8 N. A. N. A. Patented [2]
Metal complex derivative 3 DM31BMP N. A. N. A. Patented [2]
Palmarumycin derivative 1 DM859ZQ N. A. N. A. Patented [2]
Palmarumycin derivative 2 DMRLWZI N. A. N. A. Patented [2]
Palmarumycin derivative 3 DM198BY N. A. N. A. Patented [2]
Palmarumycin derivative 4 DMZGI0R N. A. N. A. Patented [2]
PMID27977313-Compound-17 DMTI5E3 N. A. N. A. Patented [2]
PMID27977313-Compound-18 DMIA3GH N. A. N. A. Patented [2]
PMID27977313-Compound-19 DM5JSI3 N. A. N. A. Patented [2]
PMID27977313-Compound-27 DMVYO09 N. A. N. A. Patented [2]
PMID27977313-Compound-28 DM67NBI N. A. N. A. Patented [2]
PMID27977313-Compound-29 DMIF7KG N. A. N. A. Patented [2]
PMID27977313-Compound-30 DMWHAKG N. A. N. A. Patented [2]
PMID27977313-Compound-31 DMBL5J9 N. A. N. A. Patented [2]
PMID27977313-Compound-32 DMZNM52 N. A. N. A. Patented [2]
PMID27977313-Compound-39 DM0LB21 N. A. N. A. Patented [2]
PMID27977313-Compound-42 DML4C6D N. A. N. A. Patented [2]
PMID27977313-Compound-43 DMTFLVN N. A. N. A. Patented [2]
PMID27977313-Compound-44 DM9S2UP N. A. N. A. Patented [2]
PMID27977313-Compound-45 DMSZ0GE N. A. N. A. Patented [2]
PMID27977313-Compound-46 DMGF04T N. A. N. A. Patented [2]
PMID27977313-Compound-47 DMI61KF N. A. N. A. Patented [2]
PMID27977313-Compound-48 DM4EFRL N. A. N. A. Patented [2]
PMID27977313-Compound-5 DMTUNW4 N. A. N. A. Patented [2]
PMID27977313-Compound-6 DMCUAO9 N. A. N. A. Patented [2]
PMID27977313-Compound-7 DMWIMN9 N. A. N. A. Patented [2]
PMID27977313-Compound-8 DMYFV3D N. A. N. A. Patented [2]
PMID27977313-Compound-Figure4b DMJ6CI5 N. A. N. A. Patented [2]
PMID27977313-Compound-Figure6C DMICBFK N. A. N. A. Patented [2]
Terpyridineplatinum(II) complexe 1 DMFMZCW N. A. N. A. Patented [2]
Terpyridineplatinum(II) complexe 2 DMLUYR0 N. A. N. A. Patented [2]
Terpyridineplatinum(II) complexe 3 DM54EFD N. A. N. A. Patented [2]
Terpyridineplatinum(II) complexe 4 DMOV86T N. A. N. A. Patented [2]
Terpyridineplatinum(II) complexe 5 DMI4MJ2 N. A. N. A. Patented [2]
Triazole gold complexe 1 DMCWES7 N. A. N. A. Patented [2]
Triazole gold complexe 2 DMJON7D N. A. N. A. Patented [2]
Triazole gold complexe 3 DM5TILQ N. A. N. A. Patented [2]
⏷ Show the Full List of 57 Patented Agent(s)
5 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide DM8RY7G Discovery agent N.A. Investigative [3]
4,6-dinitrobenzo[c][1,2,5]thiadiazole DMWDYLR Discovery agent N.A. Investigative [4]
5,8-Dihydroxy-1,4-naphthoquinone DMOCEPA Malaria 1F40-1F45 Investigative [5]
Bis(2,4-dinitrophenyl)sulfane DMEW49T Discovery agent N.A. Investigative [4]
Flavin-Adenine Dinucleotide DM5S4GK Discovery agent N.A. Investigative [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556.
3 Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schis... J Med Chem. 2009 Oct 22;52(20):6474-83.
4 Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2283-92.
5 Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents. 2007 Jul;30(1):4-10.
6 Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66.